03 Dec 2018
LIBERUM: Shield Therapeutics* - FDA accepts Feraccru filing, approval decision likely in 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LIBERUM: Shield Therapeutics* - FDA accepts Feraccru filing, approval decision likely in 2019
Shield Therapeutics Plc (STX:LON) | 2.0 0 0.0% | Mkt Cap: 15.6m
- Published:
03 Dec 2018 -
Author:
Graham Doyle -
Pages:
2